ArticleCancer immunology research2025

Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Elliott J Brea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.